February 7, 2024

cfHPV-DNA: A new prognostic biomarker in HPV driven OPSCC


Watch as the speakers explore the role cfHPV-DNA plays in cancer prognosis, and what barriers biopharma companies face in incorporating cfHPV-DNA into their clinical trial design. The speakers discuss how pharma manufacturers, HCPs and patients can collaborate to help overcome these barriers.

cfHPV-DNA webinar speakers